April 27, 2026
Fathom Therapeutics
Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.
- Round
- Series A
- Amount raised
- $47M
- Lead investor
- Sutter Hill Ventures
- Industry
- Biopharma
- Headquarters
- New York, United States
- Employees
- 11-50
- Website
- www.atommap.com
- View profile →
Source: Crunchbase snapshot 2026-05-15